Trials / Completed
CompletedNCT05236283
Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland
Duration of Antimicrobial Treatment for Bloodstream Infections in Swiss Critically Ill Patients - Retrospective Double Center Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 395 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of the retrospective cohort study is to describe the actual current practice of antibiotic treatment duration for bloodstream infections in critically ill patients at two tertiary hospitals (ICU Inselspital Bern and ICU CHUV Lausanne), to examine patient, pathogen and infectious syndrome factors associated with selection of shortened treatment duration, and to describe the expected time course of clinical resolution among bacteremic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood Culture | Blood Culture |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-03-01
- Completion
- 2022-03-30
- First posted
- 2022-02-11
- Last updated
- 2023-01-26
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05236283. Inclusion in this directory is not an endorsement.